Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) has been assigned a consensus recommendation of “Hold” from the five ratings firms that are covering the firm, MarketBeat.com reports. One analyst has rated the stock with a sell rating, three have issued a hold rating and one has assigned a buy rating to the company. The average […]
Marquette Asset Management LLC Has $105,000 Position in Nektar Therapeutics (NASDAQ:NKTR) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Nektar Therapeutics to Post FY2026 Earnings of ($0.95) Per Share, Zacks Research Forecasts (NASDAQ:NKTR) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
William Blair reaffirmed their market perform rating on shares of Nektar Therapeutics (NASDAQ:NKTR – Free Report) in a research report released on Tuesday morning, RTT News reports. William Blair also issued estimates for Nektar Therapeutics’ Q1 2024 earnings at ($0.22) EPS, Q2 2024 earnings at ($0.22) EPS, Q3 2024 earnings at ($0.23) EPS, Q4 2024 […]
Primecap Management Co. CA trimmed its stake in Nektar Therapeutics (NASDAQ:NKTR – Free Report) by 11.7% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 7,197,983 shares of the biopharmaceutical company’s stock after selling 951,893 shares during the period. Primecap Management […]